Dr. Kennedy Lishimpi, the Permanent Secretary for Technical Services, marked a significant step forward in Zambia's health sector with the launch of the National Multi-Pathogen Diagnostic Programme (NMPDP).
The event brought together an array of distinguished guests, including Provincial Health Directors, representatives from the Ministry of Health, the US Centers for Disease Control and Prevention (CDC), USAID, the Centers for Infectious Diseases Research in Zambia (CIDRZ), and several other key organizations dedicated to public health.
Dr. Lishimpi emphasized the government's unwavering commitment to achieving universal health coverage and providing quality healthcare services to all Zambians.
He highlighted the substantial strides made by the Ministry of Health in enhancing laboratory capacities, citing the establishment of 24 PCR laboratories and 255 point-of-care testing laboratories across the country.
Despite these advancements, Dr. Lishimpi acknowledged the persistent gaps in microbiology and molecular testing capabilities, particularly in rural areas.
Addressing these deficiencies is crucial for the successful implementation of the NMPDP, which aims to leverage advanced molecular and microbiology techniques, including open PCR and genomic sequencing, to enhance the country's diagnostic capabilities.
The primary objectives of the stakeholder engagement meeting included raising awareness about the NMPDP, sharing experiences around infectious disease diagnosis and management, and securing commitments of support from all stakeholders.
The meeting also aimed to streamline roles and responsibilities and integrate various partner-supported efforts into a single sustainable system for the Ministry of Health.
Dr. Lishimpi outlined the key components being enhanced to realize a robust laboratory system, such as sample transportation, laboratory information management systems, power backup systems, quality management systems, and the supply chain for essential laboratory commodities.
Significant resources have also been committed to upgrading laboratory infrastructure and training personnel.
The NMPDP, a transformative initiative, is designed to address significant gaps in the current diagnostic landscape.
By implementing advanced diagnostic methods, the program will enable the timely and accurate detection of a wide range of pathogens, including those causing respiratory illnesses, sexually transmitted infections (STIs), and central nervous system (CNS) infections.
Dr. Lishimpi underscored the importance of collaboration and partnership in achieving the ambitious goals of the NMPDP.
He acknowledged the invaluable support from the US CDC through PEPFAR and the critical role of CIDRZ as the implementing partner for the program.
The active participation and insights of all stakeholders are essential to shaping a robust and effective program.
As the meeting concluded, Dr. Lishimpi officially opened the stakeholder engagement meeting, calling for determination and unity in efforts to strengthen laboratory capabilities and improve the health and well-being of the Zambian people.
The launch of the NMPDP marks a new era in Zambia's fight against infectious diseases, aligning with the Ministry of Health's mission to provide equitable access to quality health services and contributing to the nation's socio-economic development.
Comments